SOLOXINE (LEVOTHYROXINE SODIUM TABLETS 0.3MG) DIN 02158531
Status: Dormant
Holder: VIRBAC AH, INC.
Health Canada record
| Active ingredient(s) | LEVOTHYROXINE SODIUM .3 MG |
|---|
| Dosage form | Tablet |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 31-Dec-1995 |
|---|
| Current status date | 31-Jul-2018 |
|---|
| Source | Health Canada DPD |
|---|
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing LEVOTHYROXINE SODIUM .3 MG
| DIN | Product | Company | Form | Strength | Status |
|---|
| 00012319 | ELTROXIN TAB 300MCG | GLAXO CANADA INC | Tablet | LEVOTHYROXINE SODIUM .3 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 528 | 2004-04-05 | New Drug Submission (NDS) | |
| 7164 | 1995-03-17 | New Drug Submission (NDS) | |
Request a quote for SOLOXINE (LEVOTHYROXINE SODIUM TABLETS 0.3MG)
How to read a Canadian DIN record